IN8bio, Inc.
INAB
$1.75
-$0.03-1.69%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -31.36% | 0.97% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -23.73% | -8.11% | |||
| Operating Income | 23.73% | 8.11% | |||
| Income Before Tax | 24.34% | 8.22% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 24.34% | 8.22% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 24.34% | 8.22% | |||
| EBIT | 23.73% | 8.11% | |||
| EBITDA | 22.81% | 9.76% | |||
| EPS Basic | 31.33% | 37.99% | |||
| Normalized Basic EPS | 31.32% | 37.99% | |||
| EPS Diluted | 31.33% | 37.99% | |||
| Normalized Diluted EPS | 31.32% | 37.99% | |||
| Average Basic Shares Outstanding | 10.16% | 48.03% | |||
| Average Diluted Shares Outstanding | 10.16% | 48.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||